{# ── Non-reliance notice. Reaching the live report with one of these means it did not meet the blocking bar (the 4.02 names this period outside the Item 4.02 body) or the viewer is staff. Either way the reader must not take the figures at face value. ── #}

Get notified when UHS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: UHS UNIVERSAL HEALTH SERVICES INC 8-K

UHS cuts 2026 EPS guidance ~3% on Medicaid headwinds despite 10% Q2 earnings growth

Filed July 28, 2026 · Period ending July 27, 2026 · ~2 min read

Key Changes

  • high

    Revised full-year 2026 adjusted EPS midpoint to $22.97 (down 2.6% from prior $23.58) and adjusted EBITDA to $2.663B (down 1.9% from $2.715B) citing operating trends and Medicaid supplemental payment changes.

    Exhibit 99.1 view on EDGAR →
  • high

    Q2 2026 EPS of $5.98 rose 10% YoY on 8.3% revenue growth to $4.638B, aided by $72M net pre-tax benefit from Florida Medicaid directed payment program adjustment.

    Exhibit 99.1 view on EDGAR →
  • high

    Revised guidance excludes incremental Florida Medicaid directed payment benefits beyond Q2 2026 pending CMS approval of increased program size for periods after September 30, 2025.

    Exhibit 99.1 view on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (IMMR 10-K) is open in full — no account needed.

Partner

Trade UHS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jul 29, 2026 · How we verify